Healthcare & Insurance
Pilot Study for New Depression Treatment Protocol with Nexstim NBT® System Starts in Kuopio University Hospital
Company Announcement, Inside information, Helsinki, 22 September 2020 at 9.30 am (EEST) Pilot Study for New Depression Treatment Protocol with Nexstim NBT® System Starts in Kuopio University Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that a pilot study on the
Tuesday, September 22, 2020
Nicox’s ZERVIATE Receives IND Approval in China
Press ReleaseNicox’s ZERVIATETM Receives IND Approval in China September 22, 2020 – release at 7:30 am Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that its partner, Ocumension Therapeutics, has received
Tuesday, September 22, 2020
Basilea reports data from poster presentations at ESMO Virtual Congress 2020
Gene expression data may explain differences in clinical adverse event profiles of FGFR inhibitorsAntitumor activity of derazantinib in preclinical cancer models with FGFR aberrations supports planned gastric cancer studyFull results from the completed phase 1 study in patients with brain cancer
Tuesday, September 22, 2020
Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Principia Biopharma Inc.
Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Principia Biopharma Inc. PARIS – September 22, 2020 - Sanofi announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), applicable to Sanofi’s
Tuesday, September 22, 2020
Santhera Announces Publication of Long-Term Clinical Data with Vamorolone in Patients with Duchenne Muscular Dystrophy
Pratteln, Switzerland, September 22, 2020 – Santhera Pharmaceuticals (SIX: SANN) announces that partner ReveraGen Biopharma Inc. and their academic collaborators have published new open-label, long-term clinical data on the safety, tolerability and efficacy of vamorolone in patients with
Tuesday, September 22, 2020
CORRECTING and REPLACING - Zogenix Appoints Three Industry Leaders to Its Board of Directors
Correction: In this updated news release issued September 21, 2020 by Zogenix, Inc, the name of the organization, WorldWideWomen, has been corrected. The full corrected press release follows. EMERYVILLE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Zogenix (Nasdaq: ZGNX), a global
Tuesday, September 22, 2020
Aileron Therapeutics Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital
WATERTOWN, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (NASDAQ: ALRN), today announced it has entered into a common stock purchase agreement (“Purchase Agreement”) for up to $15 million with Lincoln Park Capital Fund, LLC (“LPC”), a Chicago-based institutional
Monday, September 21, 2020
AMERISAFE Announces 2020 Third Quarter Earnings Release and Conference Call Schedule
DERIDDER, La., Sept. 21, 2020 (GLOBE NEWSWIRE) -- AMERISAFE, Inc. (Nasdaq: AMSF), a specialty provider of workers’ compensation insurance focused on high hazard industries, today announced it will release its 2020 third quarter financial results on Wednesday, October 28, 2020 after the market
Monday, September 21, 2020
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020
Conference call and webcast on Tuesday, September 22 at 2:30 pm CET/8:30 am ETTRYbeCA-1 Phase 3 trial in second-line metastatic pancreatic cancer: More than 90% of the planned 500 patients enrolled Fast-Track designation granted by U.S. FDAInterim superiority analysis expected in Q1 2021; final
Monday, September 21, 2020
Morphic Therapeutic to Present at the Jefferies Next Generation IBD Therapeutics Virtual Summit
WALTHAM, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment of serious chronic diseases, today announced two presentations at the Jefferies Next Generation
Monday, September 21, 2020
Hallmark Financial Announces Resignation of Chief Financial Officer
DALLAS, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Hallmark Financial Services, Inc. (“Hallmark Financial” or “Company”) (NASDAQ: HALL), a specialty property and casualty insurance company, today announced that on September 15, 2020, Jeff Passmore, Chief Financial Officer, submitted his
Monday, September 21, 2020
BioLife Sciences (BLFE) Announces Distribution Agreement With BeMotion Inc.
Toronto, Sept. 21, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --BioLife Sciences Inc. (OTC Markets: BLFE) announced today that it has entered into an agreement with BeMotion Inc. to become a licensed distributor of the company’s innovative technology products. Under the terms of the
Monday, September 21, 2020
Frederick 911 Communications Center Promotes the Success of SteraMist After Purchase of Surface Unit
BEVERLY HILLS, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQB:TOMZD), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a
Monday, September 21, 2020
ERYTECH establishes a financing facility with the implementation of an at-the-market program on Nasdaq with Cowen
LYON, France, Sept. 21, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris : ERYP - Nasdaq : ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances in red blood cells (the "Company"), today announced the implementation of an
Monday, September 21, 2020
Capital Senior Living Announces CFO Transition
Carey Hendrickson to Step Down on November 6, 2020 Company Initiates Search for a Successor DALLAS, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU), one of the nation’s largest operators of senior living communities, today announced that
Monday, September 21, 2020
Aziyo Biologics Announces New Appointments to Board of Directors
SILVER SPRING, Md., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today that Maybelle
Monday, September 21, 2020
Apellis Announces Late-Breaking Presentation of Targeted C3 Therapy Pegcetacoplan in Patients with Geographic Atrophy (GA) at EURETINA 2020
New analysis of age-related macular degeneration (AMD) progression in Phase 2 FILLY study accepted as late-breaking oral presentation at European Society of Retina Specialists Congress (EURETINA)Pegcetacoplan targets C3, and has the potential to control the irreversible lesion growth in GA, an
Monday, September 21, 2020
Dyne Therapeutics Announces Closing of Initial Public Offering
WALTHAM, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases, today announced the closing of its initial public offering of 14,089,314
Monday, September 21, 2020
Silk Road Medical Strengthens Leadership Team
SUNNYVALE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it is strengthening its leadership team with two appointments. William Whealon, Ph.D. has joined the
Monday, September 21, 2020
Protara Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
NEW YORK, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that it intends to offer and sell shares of its common
Monday, September 21, 2020
